ACA
TARO

Apis Capital Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Apis Capital Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$4.94M Sell
34,600
-6,250
-15% -$874K 6.84% 3
2015
Q2 		$5.87M Sell
40,850
-41,588
-50% -$5.93M 6.59% 5
2015
Q1 		$9.77M Buy
82,438
+11,088
+16% +$1.71M 13.35% 1
2014
Q4 		$10.6M Buy
+71,350
New +$10.5M 11.75% 1

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Apis Capital Advisors's TARO Position: Q3 2015 in Review

Apis Capital Advisors reduced its Taro Pharmaceutical Industries Ltd. (TARO) stake by 15% in Q3 2015, selling an estimated $874K and leaving 34,600 shares worth $4.94M. The position accounts for 6.84% of the portfolio, ranked #3.

Apis Capital Advisors first reported a position in TARO in Q4 2014 and has held it in 4 quarters since. The position peaked at $10.6M in Q4 2014. 121 funds tracked by Wall St. Rank hold TARO as of Q3 2015.

  • Apis Capital Advisors held 34,600 shares of Taro Pharmaceutical Industries Ltd. worth $4.94M as of Q3 2015.
  • Apis Capital Advisors sold 6,250 Taro Pharmaceutical Industries Ltd. shares in Q3 2015, an estimated $874K.
  • Taro Pharmaceutical Industries Ltd. made up 6.84% of Apis Capital Advisors's portfolio in Q3 2015, its #3 holding.
  • Apis Capital Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and has held it in 4 quarters since.
  • Apis Capital Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $10.6M in Q4 2014.
  • 121 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2015.

Based on Apis Capital Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.